NCT00199940View on ClinicalTrials.gov

Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

April 30, 2007

Conditions
SchizophreniaAffective DisordersPsychotic DisorderPsychotic Mood Disorder
Interventions
DRUG

Ziprasidone

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER

NCT00199940 - Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness | Biotech Hunter | Biotech Hunter